|
1
|
Adamus G: The role of recoverin in
autoimmunity. Neuronal Calcium Sensor Proteins. Philippov P and
Koch KW: Nova Science Publishers, Inc.; New York, NY: pp. 181–199.
2006
|
|
2
|
Dizhur AM, Nekrasova EN and Filippov PP:
New 26 kDa protein specific for photoreceptor cells, capable of
binding with immobilized delipidized rhodopsin. Biokhimiya.
56:225–229. 1991.PubMed/NCBI
|
|
3
|
Dizhoor AM, Ray S, Kumar S, et al:
Recoverin: a calcium sensitive activator of retinal rod guanylate
cyclase. Science. 251:915–918. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Philippov PP, Senin II and Koch KW:
Recoverin: a calcium-dependent regulator of the visual
transduction. Neuronal Calcium Sensor Proteins. Philippov P and
Koch KW: Nova Science Publishers, Inc.; New York, NY: pp. 139–151.
2006
|
|
5
|
Eichmüller SB and Bazhin AV: Onconeural
versus paraneoplastic antigens. Cur Med Chem. 14:2489–2494.
2007.
|
|
6
|
Polans AS, Buczylko J, Crabb J and
Palczewski K: A photoreceptor calcium binding protein is recognized
by autoantibodies obtained from patients with cancer-associated
retinopathy. J Cell Biol. 112:981–989. 1991. View Article : Google Scholar
|
|
7
|
Polans AS, Witkowska D, Haley TL, et al:
Recoverin, a photoreceptor-specific calcium-binding protein, is
expressed by the tumor of a patient with cancer-associated
retinopathy. Proc Natl Acad Sci USA. 92:9176–9180. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bazhin AV, Shifrina ON, Savchenko MS, et
al: Low titer autoantibodies against recoverin in sera of patients
with small cell lung cancer but without a loss of vision. Lung
Cancer. 34:99–104. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Savchenko MS, Bazhin AV, Shifrina ON, et
al: Antirecoverin autoantibodies in the patient with non-small lung
cancer but without cancer-associated retinopathy. Lung Cancer.
41:363–367. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bazhin AV, Savchenko MS, Shifrina ON, et
al: Recoverin as a paraneoplastic antigen in lung cancer: the
occurrence of anti-recoverin autoantibodies in sera and recoverin
in tumors. Lung Cancer. 44:193–198. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bazhin AV, De Smet C, Golovastova MO, et
al: Aberrant demethylation of the recoverin gene is involved in the
aberrant expression of recoverin in cancer cells. Exp Dermatol.
19:1023–1025. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bazhin AV, Shifrina ON, Savchenko MS, et
al: Application of ELISA and immunoblotting methods for detection
of anti-recoverin autoantibodies in sera of small-cell lung
carcinoma patients. Pulmonology. 13:62–65. 2003.
|
|
13
|
Senin II, Zargarov AA, Alekseev AM, et al:
N-Myristoylation of recoverin enhances its efficiency as an
inhibitor of rhodopsin kinase. FEBS Lett. 376:87–90. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maeda A, Ohguro H, Maeda T, et al:
Aberrant expression of photoreceptor-specific calcium-binding
protein (recoverin) in cancer cell lines. Cancer Res. 60:1914–1920.
2000.PubMed/NCBI
|
|
15
|
Bazhin AV, Schadendorf D, Willner N, et
al: Photoreceptor proteins as cancer-retina antigens. Int J Cancer.
120:1268–1276. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Graus F, Cordon-Cardo C and Posner JB:
Neuronal antinuclear antibody in sensory neuropathy from lung
cancer. Neurology. 35:538–543. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hersh B, Dalmau J, Dangond F, et al:
Paraneoplastic opsoclonus-myoclonus associated with anti-Hu
antibody. Neurology. 44:1754–1755. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dalmau J, Furneaux HM, Gralla RJ, et al:
Detection of anti-Hu antibody in the serum of patients with small
cell lung cancer – a quantitative western blot analysis. Ann
Neurol. 27:544–552. 1990.
|
|
19
|
Drlicek M, Bianchi G, Bogliun G, et al:
Antibodies of the anti-Yo and anti-Ri type in the absence of
paraneoplastic neurological syndromes: a long-term survey of
ovarian cancer patients. J Neurol. 244:85–89. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bazhin AV, Dalke C, Willner N, et al:
Cancer-retina antigens as potential paraneoplastic antigens in
melanoma-associated retinopathy. Int J Cancer. 124:140–149. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsuo S, Ohguro H, Ohguro I and Nakazawa
M: Clinico-pathological roles of aberrantly expressed recoverin in
malignant tumor cells. Ophthalmol Res. 43:139–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Voltz R, Gultekin SH, Rosenfeld MR, et al:
A serologic marker of paraneoplastic limbic and brain-stem
encephalitis in patients with testicular cancer. N Eng J Med.
340:1788–1795. 1999. View Article : Google Scholar : PubMed/NCBI
|
